Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Fine Chemicals. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1166672C details a novel Ru-H4-BINAP-diamine complex for asymmetric hydrogenation, offering high enantioselectivity and cost-effective manufacturing for chiral alcohol intermediates.
Patent CN102978267B reveals advanced enzymatic glutathione production with ATP regeneration. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN112961054A reveals a scalable iron-catalyzed method for aromatic difluoromethylation, offering cost-effective routes for high-purity pharmaceutical intermediates.
Patent CN101747304B reveals a green Zn/PEG/H2O method for vinyl sugar synthesis, offering high yields and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN105734028A reveals high-efficiency epoxide hydrolase mutants for R-epichlorohydrin production, offering superior stability and supply chain reliability.
Novel 4-step route avoids hazardous LiAlH4 reduction. Offers cost reduction in pharma intermediate manufacturing with high purity and scalability.
Patent CN101265147A details a ligand-free Pd-catalyzed direct arylation method. This technology offers significant cost reduction in fine chemical manufacturing by eliminating pre-functionalization steps.
Patent CN102876734B details a novel carbonyl reductase for high-purity chiral alcohol production, offering significant cost and supply chain advantages for API intermediates.
Advanced catalytic hydrogenation process for high-purity 2-amino-4-acetamidoanisole. Reduces waste and improves yield for disperse dye manufacturing.
Patent CN103360287B enables high-purity pharmaceutical intermediates via selective oxidation. Reduces waste and enhances supply chain reliability for global buyers.
Patent CN113583992A reveals a novel RsRedAm enzyme for efficient secondary amine synthesis, offering mild conditions and high selectivity for pharmaceutical intermediates.
Patent CN1376659A reveals a safe metal borohydride reduction system for high-purity chiral intermediates, offering significant cost and supply chain advantages.
Patent CN111689933B details a green one-pot reductive amination using biomass-derived HMF and nitrobenzene, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN100584827C discloses efficient synthesis of chiral ligands from L-prolinol or ephedrine. High yield, room temperature reaction, and superior enantioselectivity for pharmaceutical intermediates.
Patent CN111606791A details a green oxidation method using Fe(III)/NHPI. Offers high purity intermediates for pharma with reduced heavy metal contamination risks.
Patent CN104710259A details a novel Ru/C catalyzed amide synthesis using air oxidation, offering high purity and cost reduction for pharmaceutical intermediate manufacturing.
Patent CN102766023A reveals a novel two-step route avoiding azeotropes, offering cost reduction in fluorochemical manufacturing and reliable supply chain solutions.
Advanced synthesis of (E)-2,4,5-trimethoxy-1-propenylbenzene via novel propionylation and dehydration. High purity >99%, low cost, scalable process for pharmaceutical intermediates.
Patent CN101824057A details a scalable four-step route for O-glycoside nitrones, offering cost reduction in pharmaceutical intermediate manufacturing via mild glycosylation.
Novel patent CN116283604B details high-purity spermidine synthesis offering scalable production and supply chain stability for global pharmaceutical manufacturers.